BackTetraLogic Pharmaceuticals Overview

TetraLogic Pharmaceuticals Other Current Assets

Track TetraLogic Pharmaceuticals's other current assets ($490K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$488106.00
73.11% YoYΔ $-1.33M vs prior year quarter

Peer average

Loading

TetraLogic Pharmaceuticals Other Current Assets History

Loading

TetraLogic Pharmaceuticals vs. peers: Other Current Assets Comparison

Loading

TetraLogic Pharmaceuticals Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

TetraLogic Pharmaceuticals (TLOG) FAQ

As of the most recent data (September 2016), TLOG shows a other current assets of $490K. That compares with $1.8M in the prior-year period — down 73.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TLOG's other current assets is now $490K (was $1.8M) — a 73.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether TetraLogic Pharmaceuticals is outperforming or lagging.

Tracking TLOG's other current assets over time shows whether TetraLogic Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $490K That compares with $1.8M in the prior-year period — down 73.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has TetraLogic Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $490K) with ownership activity and broader fundamentals.

TetraLogic Pharmaceuticals's other current assets is $490K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.